These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 28460544

  • 1. Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin.
    Toikkanen V, Rinne T, Laurikka J, Porkkala H, Tarkka M, Mennander A.
    Scand J Clin Lab Invest; 2017 Sep; 77(5):315-320. PubMed ID: 28460544
    [Abstract] [Full Text] [Related]

  • 2. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery.
    Toikkanen V, Rinne T, Huhtala H, Laurikka J, Porkkala H, Tarkka M, Mennander A.
    Scand J Clin Lab Invest; 2014 Jan; 74(1):37-43. PubMed ID: 24266780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aprotinin Impacts 8-Isoprostane after Coronary Artery Bypass Grafting.
    Toikkanen V, Rinne T, Nieminen R, Moilanen E, Laurikka J, Porkkala H, Tarkka M, Mennander AA.
    Scand J Surg; 2018 Dec; 107(4):329-335. PubMed ID: 29628009
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery].
    Jin X, Chen Z, Wang M, Lü W, Zhang W, Sun J.
    Zhonghua Yi Xue Za Zhi; 2014 Mar 11; 94(9):646-50. PubMed ID: 24842200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass.
    Faulí A, Gomar C, Campistol JM, Alvarez L, Manig AM, Matute P.
    Eur J Anaesthesiol; 2005 Sep 11; 22(9):666-71. PubMed ID: 16163912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.
    Harmon DC, Ghori KG, Eustace NP, O'Callaghan SJ, O'Donnell AP, Shorten GD.
    Can J Anaesth; 2004 Dec 11; 51(10):1002-9. PubMed ID: 15574551
    [Abstract] [Full Text] [Related]

  • 16. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T, Krutzsch D, Wils M, Plötze K, Matschke K.
    Clin Hemorheol Microcirc; 2009 Dec 11; 42(4):269-77. PubMed ID: 19628892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass.
    Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT.
    Perfusion; 2003 Mar 11; 18 Suppl 1():23-31. PubMed ID: 12708762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.